Blogger Daniel MacArthur in Wired's Genetic Future blog observed that senior biotech executives are making their genomes public in what could be a "pragmatic" move to help their businesses grow by trying to convince the medical establishment (and the public) that genome sequencing will provide health benefits that outweigh the potential privacy risks. S. Pelech comments that these executives are willing to have their genome sequences revealed to the broad research community, because it may promote their business, they really have nothing to loose, and there is a slight possibility to personally benefit with researchers focused on their individual genomes. He argues that if these executives and some prominent scientists are willing to disclose their full medical, life and family histories coupled with a willingness to subject themselves to a wide barrage of medical tests and publicly disclose the results, this might actually be useful in helping to make some sense of our genetic differences. Read More...

Tags: DNA Sequencing, Industry